Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRC
5176
CALL
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.05M | ﹤0.01% |
20,900
-27,600
| -57% | -$2.58M |
|
|
FABC
5177
CALL
Fabric.AI Inc
FABC
$18.6M
| $2.05M | ﹤0.01% |
2,630
+2,478
| +1,630% | +$1.51M |
|
|
QDYN
5178
DELISTED
FlexShares Quality Dividend Dynamic Index Fund
QDYN
| $2.05M | ﹤0.01% |
40,145
-470
| -1% | -$22.6K |
|
5179
Central Garden & Pet Co Class A
CENTA
$2.35B
| $2.05M | ﹤0.01% |
70,415
-4,144
| -6% | -$121K |
|
5180
Trane Technologies
TT
$103B
| $2.04M | ﹤0.01% |
14,081
+2,155
| +18% | +$298K |
|
5181
PUT
Criteo S.A.
CRTO
$897M
| $2.04M | ﹤0.01% |
99,600
-4,900
| -5% | -$81.9K |
|
5182
John Hancock Multifactor Large Cap ETF
JHML
$1.19B
| $2.04M | ﹤0.01% |
43,097
+24,538
| +132% | +$1.1M |
|
|
ECHO
5183
EchoStar
ECHO
$26.4B
| $2.04M | ﹤0.01% |
96,366
-27,051
| -22% | -$647K |
|
|
TMHC
5184
CALL
DELISTED
Taylor Morrison
TMHC
| $2.04M | ﹤0.01% |
79,600
+20,600
| +35% | +$525K |
|
5185
Gentherm
THRM
$1.32B
| $2.04M | ﹤0.01% |
31,299
+4,026
| +15% | +$217K |
|
|
USCR
5186
DELISTED
U S Concrete, Inc.
USCR
| $2.04M | ﹤0.01% |
51,062
+30,173
| +144% | +$1.07M |
|
5187
CNA Financial
CNA
$13.7B
| $2.04M | ﹤0.01% |
52,303
-57,576
| -52% | -$1.96M |
|
5188
CALL
Teledyne Technologies
TDY
$31B
| $2.04M | ﹤0.01% |
5,200
-5,900
| -53% | -$2.12M |
|
5189
Innovator US Equity Ultra Buffer ETF July
UJUL
$298M
| $2.04M | ﹤0.01% |
77,001
+16,018
| +26% | +$418K |
|
5190
Entegris
ENTG
$23.5B
| $2.04M | ﹤0.01% |
21,178
-17,696
| -46% | -$1.55M |
|
5191
iShares US Consumer Discretionary ETF
IYC
$1.19B
| $2.04M | ﹤0.01% |
+28,865
| New | +$1.92M |
|
5192
PUT
Pacira BioSciences
PCRX
$943M
| $2.04M | ﹤0.01% |
34,000
+6,500
| +24% | +$381K |
|
|
PETQ
5193
CALL
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $2.03M | ﹤0.01% |
52,900
-18,200
| -26% | -$564K |
|
5194
Fidelity Dividend ETF for Rising Rates
FDRR
$765M
| $2.03M | ﹤0.01% |
55,117
+18,855
| +52% | +$651K |
|
5195
CALL
Ameresco
AMRC
$1.38B
| $2.03M | ﹤0.01% |
38,800
+21,800
| +128% | +$939K |
|
5196
PTC Therapeutics
PTCT
$6.13B
| $2.03M | ﹤0.01% |
33,210
+18,051
| +119% | +$1.06M |
|
5197
CALL
Xylem
XYL
$26.6B
| $2.03M | ﹤0.01% |
19,900
-21,100
| -51% | -$1.98M |
|
5198
CALL
Walker & Dunlop
WD
$1.38B
| $2.02M | ﹤0.01% |
22,000
+8,600
| +64% | +$637K |
|
5199
Phibro Animal Health
PAHC
$1.39B
| $2.02M | ﹤0.01% |
104,140
+47,907
| +85% | +$881K |
|
|
ZYXI
5200
CALL
DELISTED
Zynex
ZYXI
| $2.02M | ﹤0.01% |
165,330
+134,860
| +443% | +$1.75M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.